IBDEI1QR ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29548,1,3,0)
 ;;=3^Male Infertility,Unspec
 ;;^UTILITY(U,$J,358.3,29548,1,4,0)
 ;;=4^N46.9
 ;;^UTILITY(U,$J,358.3,29548,2)
 ;;=^5015724
 ;;^UTILITY(U,$J,358.3,29549,0)
 ;;=Z31.49^^115^1471^3
 ;;^UTILITY(U,$J,358.3,29549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29549,1,3,0)
 ;;=3^Infertility Testing
 ;;^UTILITY(U,$J,358.3,29549,1,4,0)
 ;;=4^Z31.49
 ;;^UTILITY(U,$J,358.3,29549,2)
 ;;=^5062837
 ;;^UTILITY(U,$J,358.3,29550,0)
 ;;=N97.1^^115^1471^6
 ;;^UTILITY(U,$J,358.3,29550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29550,1,3,0)
 ;;=3^Tubal Infertility
 ;;^UTILITY(U,$J,358.3,29550,1,4,0)
 ;;=4^N97.1
 ;;^UTILITY(U,$J,358.3,29550,2)
 ;;=^5015932
 ;;^UTILITY(U,$J,358.3,29551,0)
 ;;=N97.9^^115^1471^4
 ;;^UTILITY(U,$J,358.3,29551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29551,1,3,0)
 ;;=3^Infertility,Unspec
 ;;^UTILITY(U,$J,358.3,29551,1,4,0)
 ;;=4^N97.9
 ;;^UTILITY(U,$J,358.3,29551,2)
 ;;=^5015935
 ;;^UTILITY(U,$J,358.3,29552,0)
 ;;=N97.2^^115^1471^7
 ;;^UTILITY(U,$J,358.3,29552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29552,1,3,0)
 ;;=3^Uterine Infertility
 ;;^UTILITY(U,$J,358.3,29552,1,4,0)
 ;;=4^N97.2
 ;;^UTILITY(U,$J,358.3,29552,2)
 ;;=^5015933
 ;;^UTILITY(U,$J,358.3,29553,0)
 ;;=N97.8^^115^1471^8
 ;;^UTILITY(U,$J,358.3,29553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29553,1,3,0)
 ;;=3^Vaginal Infertility
 ;;^UTILITY(U,$J,358.3,29553,1,4,0)
 ;;=4^N97.8
 ;;^UTILITY(U,$J,358.3,29553,2)
 ;;=^5015934
 ;;^UTILITY(U,$J,358.3,29554,0)
 ;;=D21.9^^115^1472^1
 ;;^UTILITY(U,$J,358.3,29554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29554,1,3,0)
 ;;=3^Benign Neoplasm,Connective & Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,29554,1,4,0)
 ;;=4^D21.9
 ;;^UTILITY(U,$J,358.3,29554,2)
 ;;=^5002040
 ;;^UTILITY(U,$J,358.3,29555,0)
 ;;=L68.0^^115^1472^2
 ;;^UTILITY(U,$J,358.3,29555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29555,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,29555,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,29555,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,29556,0)
 ;;=E28.1^^115^1472^3
 ;;^UTILITY(U,$J,358.3,29556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29556,1,3,0)
 ;;=3^Hyperandrogenism
 ;;^UTILITY(U,$J,358.3,29556,1,4,0)
 ;;=4^E28.1
 ;;^UTILITY(U,$J,358.3,29556,2)
 ;;=^5002748
 ;;^UTILITY(U,$J,358.3,29557,0)
 ;;=E22.1^^115^1472^4
 ;;^UTILITY(U,$J,358.3,29557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29557,1,3,0)
 ;;=3^Hyperprolactinemia
 ;;^UTILITY(U,$J,358.3,29557,1,4,0)
 ;;=4^E22.1
 ;;^UTILITY(U,$J,358.3,29557,2)
 ;;=^60265
 ;;^UTILITY(U,$J,358.3,29558,0)
 ;;=E05.90^^115^1472^5
 ;;^UTILITY(U,$J,358.3,29558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29558,1,3,0)
 ;;=3^Hyperthyroidism w/o Thyrotoxic Crisis/Storm
 ;;^UTILITY(U,$J,358.3,29558,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,29558,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,29559,0)
 ;;=E03.9^^115^1472^6
 ;;^UTILITY(U,$J,358.3,29559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29559,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,29559,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,29559,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,29560,0)
 ;;=E04.0^^115^1472^7
 ;;^UTILITY(U,$J,358.3,29560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29560,1,3,0)
 ;;=3^Nontoxic Diffuse Goiter
 ;;^UTILITY(U,$J,358.3,29560,1,4,0)
 ;;=4^E04.0
 ;;^UTILITY(U,$J,358.3,29560,2)
 ;;=^5002477
 ;;^UTILITY(U,$J,358.3,29561,0)
 ;;=E89.0^^115^1472^8
 ;;^UTILITY(U,$J,358.3,29561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29561,1,3,0)
 ;;=3^Postprocedural Hypothyroidism
 ;;^UTILITY(U,$J,358.3,29561,1,4,0)
 ;;=4^E89.0
